Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis

Neurobiology of Disease

Volumn 39, Issue 1, 2010, Pages 53-60

  Qureshi, Irfan A ^a   Mehler, Mark F ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Chromatin; DNA methylation; Epigenetic; Epilepsy; Histone; Long noncoding RNA (lncRNA); MicroRNA (miRNA); Noncoding RNA (ncRNA); Repressor element 1 silencing transcription factor neuron restrictive silencer factor (REST NRSF); RNA editing

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DNA METHYLTRANSFERASE; FRAGILE X MENTAL RETARDATION PROTEIN; KAINIC ACID; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2; NEUROTRANSMITTER RECEPTOR; RNA;

CELL TYPE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; DISEASE COURSE; DNA METHYLATION; EPIGENETICS; EPILEPSY; EPILEPTOGENESIS; GENE DUPLICATION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; HOMEOSTASIS; HUMAN; NERVE CELL PLASTICITY; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; RNA EDITING; TRANSCRIPTION REGULATION;

ANIMALS; EPIGENESIS, GENETIC; EPIGENOMICS; EPILEPSY; HUMANS;

EID: 77952887283     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.02.005     Document Type: Review

References (92)

1. Abidi F.E., et al. Mutations in JARID1C are associated with X-linked mental retardation, short stature and hyperreflexia. J. Med. Genet. 2008, 45:787-793.
2. Abrajano J.J., et al. Differential deployment of REST and CoREST promotes glial subtype specification and oligodendrocyte lineage maturation. PLoS ONE 2009, 4:e7665.
3. Abrajano J.J., et al. REST and CoREST modulate neuronal subtype specification, maturation and maintenance. PLoS ONE 2009, 4:e7936.
4. Abu-Elneel K., et al. Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics 2008, 9:153-161.
5. Aid T., et al. Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res. 2007, 85:525-535.
6. Amaral P.P., et al. The eukaryotic genome as an RNA machine. Science 2008, 319:1787-1789.
7. Amir R.E., et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 1999, 23:185-188.
8. Andrade D.M. Genetic basis in epilepsies caused by malformations of cortical development and in those with structurally normal brain. Hum. Genet. 2009, 126:173-193.
9. Athanasiadis A., et al. Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol. 2004, 2:e391.
10. Bassuk A.G., et al. A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome. Am. J. Hum. Genet. 2008, 83:572-581.
11. Baujat G., Cormier-Daire V. Sotos syndrome. Orphanet J. Rare Dis. 2007, 2:36.
12. Becq H., et al. Differential properties of dentate gyrus and CA1 neural precursors. J. Neurobiol. 2005, 62:243-261.
13. Blow M., et al. A survey of RNA editing in human brain. Genome Res. 2004, 14:2379-2387.
14. Blow M.J., et al. RNA editing of human microRNAs. Genome Biol. 2006, 7:R27.
15. Bond A.M., et al. Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry. Nat. Neurosci. 2009, 12:1020-1027.
16. Bransteitter R., et al. The current structural and functional understanding of APOBEC deaminases. Cell. Mol. Life Sci. 2009, 66:3137-3147.
17. Brusa R., et al. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 1995, 270:1677-1680.
18. Cairns B.R. The logic of chromatin architecture and remodelling at promoters. Nature 2009, 461:193-198.
19. Capovilla G., et al. Conceptual dichotomies in classifying epilepsies: partial versus generalized and idiopathic versus symptomatic (April 18-20, 2008, Monreale, Italy). Epilepsia 2009, 50:1645-1649.
20. 2 receptor-mediated transmission in the striatum. J. Neurosci. 2007, 27:8885-8892.
21. Cheever A., Ceman S. Translation regulation of mRNAs by the fragile X family of proteins through the microRNA pathway. RNA Biol. 2009, 6:175-178.
22. Cheng H.Y., et al. microRNA modulation of circadian-clock period and entrainment. Neuron 2007, 54:813-829.
23. Crosio C., et al. Chromatin remodeling and neuronal response: multiple signaling pathways induce specific histone H3 modifications and early gene expression in hippocampal neurons. J. Cell Sci. 2003, 116:4905-4914.
24. Deutsch S.I., et al. Sodium butyrate, an epigenetic interventional strategy, attenuates a stress-induced alteration of MK-801's pharmacologic action. Eur. Neuropsychopharmacol. 2008, 18:565-568.
25. Deutsch S.I., et al. An epigenetic intervention interacts with genetic strain differences to modulate the stress-induced reduction of flurazepam's antiseizure efficacy in the mouse. Eur. Neuropsychopharmacol. 2009, 19:398-401.
26. Dong E., et al. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:4676-4681.
27. Eichler S.A., et al. Glycinergic tonic inhibition of hippocampal neurons with depolarizing GABAergic transmission elicits histopathological signs of temporal lobe epilepsy. J. Cell. Mol. Med. 2008, 12:2848-2866.
28. Eleuteri S., et al. Chronic dietary administration of valproic acid protects neurons of the rat nucleus basalis magnocellularis from ibotenic acid neurotoxicity. Neurotox. Res. 2009, 15:127-132.
29. Feldman J.D., et al. KID-1, a protein kinase induced by depolarization in brain. J. Biol. Chem. 1998, 273:16535-16543.
30. Freitas R.M. Investigation of oxidative stress involvement in hippocampus in epilepsy model induced by pilocarpine. Neurosci. Lett. 2009, 462:225-229.
31. Fujimura L., et al. Prickle promotes neurite outgrowth via the Dishevelled dependent pathway in C1300 cells. Neurosci. Lett. 2009, 467:6-10.
32. Garriga-Canut M., et al. 2-Deoxy-d-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat. Neurosci. 2006, 9:1382-1387.
33. Gibbons R. Alpha thalassaemia-mental retardation, X linked. Orphanet J. Rare Dis. 2006, 1:15.
34. Gibbons R.J., et al. Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat. Genet. 2000, 24:368-371.
35. Gillies S., et al. The human neurokinin B gene, TAC3, and its promoter are regulated by neuron restrictive silencing factor (NRSF) transcription factor family. Neuropeptides 2009, 43:333-340.
36. Haas C.A., Frotscher M. Reelin deficiency causes granule cell dispersion in epilepsy. Exp. Brain Res. 2010, 200:141-149.
37. Hagerman P.J., Stafstrom C.E. Origins of epilepsy in fragile X syndrome. Epilepsy Curr. 2009, 9:108-112.
38. Hassan Y.I., Zempleni J. Epigenetic regulation of chromatin structure and gene function by biotin. J. Nutr. 2006, 136:1763-1765.
39. Higuchi M., et al. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 2000, 406:78-81.
40. A receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. Hum. Mol. Genet. 2007, 16:691-703.
41. Hogart A., et al. Chromosome 15q11-13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number. J. Med. Genet. 2009, 46:86-93.
42. Huang M.C., et al. Mutation screening of AP3M2 in Japanese epilepsy patients. Brain Dev. 2007, 29:462-467.
43. Impey S., et al. An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling. Mol. Cell. Neurosci. 2009.
44. Jacobs M.P., et al. Curing epilepsy: progress and future directions. Epilepsy Behav. 2009, 14:438-445.
45. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
46. Jessberger S., et al. Epigenetic modulation of seizure-induced neurogenesis and cognitive decline. J. Neurosci. 2007, 27:5967-5975.
47. Jia Y.H., et al. Kainate exposure suppresses activation of GluR2 subunit promoter in primary cultured cerebral cortical neurons through induction of RE1-silencing transcription factor. Neurosci. Lett. 2006, 403:103-108.
48. Khalil A.M., et al. A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome. PLoS ONE 2008, 3:e1486.
49. Klein M.E., et al. Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat. Neurosci. 2007, 10:1513-1514.
50. Kobayashi S., et al. Identification of a negative regulatory DNA element for neuronal BC1 RNA expression by RNA polymerase III. Biochim. Biophys. Acta 2000, 1493:142-150.
51. Kobow K., et al. Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy. J. Neuropathol. Exp. Neurol. 2009, 68:356-364.
52. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
53. Ladd P.D., et al. An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum. Mol. Genet. 2007, 16:3174-3187.
54. Lee J., et al. Regulatory circuit of human microRNA biogenesis. PLoS Comput. Biol. 2007, 3:e67.
55. Levenson J.M., et al. The role of reelin in adult synaptic function and the genetic and epigenetic regulation of the reelin gene. Biochim. Biophys. Acta 2008, 1779:422-431.
56. Li J.B., et al. Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science 2009, 324:1210-1213.
57. Liu D.Z., et al. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J. Cereb. Blood Flow Metab. 2010, 30:92-101.
58. Marder E., Goaillard J.M. Variability, compensation and homeostasis in neuron and network function. Nat. Rev. Neurosci. 2006, 7:563-574.
59. Mattick J.S., Mehler M.F. RNA editing, DNA recoding and the evolution of human cognition. Trends Neurosci. 2008, 31:227-233.
60. Mattick J.S., et al. RNA regulation of epigenetic processes. BioEssays 2009, 31:51-59.
61. Medina C.F., et al. Altered visual function and interneuron survival in Atrx knockout mice: inference for the human syndrome. Hum. Mol. Genet. 2009, 18:966-977.
62. Mehler M.F. Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog. Neurobiol. 2008, 86:305-341.
63. Mehler M.F., Mattick J.S. Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol. Rev. 2007, 87:799-823.
64. Meier J.C., et al. RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency. Nat. Neurosci. 2005, 8:736-744.
65. Mercer T.R., et al. Noncoding RNAs in long-term memory formation. Neuroscientist 2008, 14:434-445.
66. Mercer T.R., et al. Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 2009, 10:155-159.
67. Nelson E.D., et al. Activity-dependent suppression of miniature neurotransmission through the regulation of DNA methylation. J. Neurosci. 2008, 28:395-406.
68. Nudelman A.S., et al. Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo. Hippocampus 2009, 2009 Jun 25 [Electronic publication ahead of print].
69. Okuda H., et al. Mouse Prickle1 and Prickle2 are expressed in postmitotic neurons and promote neurite outgrowth. FEBS Lett. 2007, 581:4754-4760.
70. Qureshi I.A., Mehler M.F. Regulation of non-coding RNA networks in the nervous system-what's the REST of the story?. Neurosci. Lett. 2009, 466:73-80.
71. Rajan I., et al. Loss of the putative catalytic domain of HDAC4 leads to reduced thermal nociception and seizures while allowing normal none development. PLoS ONE 2009, 4:e6612.
72. Rakhade S.N., Jensen F.E. Epileptogenesis in the immature brain: emerging mechanisms. Nat. Rev. Neurol. 2009, 5:380-391.
73. Robertson K.D. DNA methylation and human disease. Nat. Rev. Genet. 2005, 6:597-610.
74. Schratt G. Fine-tuning neural gene expression with microRNAs. Curr. Opin. Neurobiol. 2009, 19:213-219.
75. Sharma R.P., et al. Depolarization induces downregulation of DNMT1 and DNMT3a in primary cortical cultures. Epigenetics 2008, 3:74-80.
76. Sng J.C., et al. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation. Neurosci. Lett. 2005, 386:150-155.
77. Sng J.C., et al. Histone modifications in kainate-induced status epilepticus. Eur. J. NeuroSci. 2006, 23:1269-1282.
78. Szyf M. Epigenetics, DNA methylation, and chromatin modifying drugs. Annu. Rev. Pharmacol. Toxicol. 2009, 49:243-263.
79. Tahiliani M., et al. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 2007, 447:601-605.
80. Taniura H., et al. Histone modifications in status epilepticus induced by kainate. Histol. Histopathol. 2006, 21:785-791.
81. Tsankova N.M., et al. Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J. Neurosci. 2004, 24:5603-5610.
82. Turkmen S., et al. Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypes. Eur. J. Hum. Genet. 2003, 11:858-865.
83. Tzschach A., et al. Novel JARID1C/SMCX mutations in patients with X-linked mental retardation. Hum. Mutat. 2006, 27:389.
84. Urdinguio R.G., et al. Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS ONE 2008, 3:e3669.
85. Urdinguio R.G., et al. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol. 2009, 8:1056-1072.
86. Vollmar W., et al. RNA editing (R/G site) and flip-flop splicing of the AMPA receptor subunit GluR2 in nervous tissue of epilepsy patients. Neurobiol. Dis. 2004, 15:371-379.
87. Wayman G.A., et al. An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9093-9098.
88. Wu J., Xie X. Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol. 2006, 7:R85.
89. Yang Y., et al. Complex seizure disorder caused by Brunol4 deficiency in mice. PLoS Genet. 2007, 3:e124.
90. Young J.I., et al. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:17551-17558.
91. Zempleni J., et al. Biotin and biotinidase deficiency. Expert Rev. Endocrinol. Metab. 2008, 3:715-724.
92. Zhong J., et al. BC1 regulation of metabotropic glutamate receptor-mediated neuronal excitability. J. Neurosci. 2009, 29:9977-9986.